Annual Operating Profit:
-$378.94M-$143.34M(-60.84%)Summary
- As of today, RNA annual operating income is -$378.94 million, with the most recent change of -$143.34 million (-60.84%) on December 31, 2024.
- During the last 3 years, RNA annual operating profit has fallen by -$260.88 million (-220.99%).
- RNA annual operating profit is now -3509.60% below its all-time high of -$10.50 million, reached on December 31, 2018.
Performance
RNA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Profit:
-$188.81M-$17.66M(-10.32%)Summary
- As of today, RNA quarterly operating income is -$188.81 million, with the most recent change of -$17.66 million (-10.32%) on September 30, 2025.
- Over the past year, RNA quarterly operating profit has dropped by -$90.67 million (-92.40%).
- RNA quarterly operating profit is now -8584.73% below its all-time high of -$2.17 million, reached on March 31, 2019.
Performance
RNA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Operating Profit:
-$612.46M-$90.67M(-17.38%)Summary
- As of today, RNA TTM operating income is -$612.46 million, with the most recent change of -$90.67 million (-17.38%) on September 30, 2025.
- Over the past year, RNA TTM operating profit has dropped by -$287.76 million (-88.63%).
- RNA TTM operating profit is now -28071.80% below its all-time high of -$2.17 million, reached on March 31, 2019.
Performance
RNA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
RNA Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -60.8% | -92.4% | -88.6% |
| 3Y3 Years | -221.0% | -320.2% | -272.9% |
| 5Y5 Years | -2086.3% | -1546.7% | -2088.6% |
RNA Operating Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -221.0% | at low | -320.2% | at low | -272.9% | at low |
| 5Y | 5-Year | -2086.3% | at low | -1546.7% | at low | -2088.6% | at low |
| All-Time | All-Time | -3509.6% | at low | -8584.7% | at low | >-9999.0% | at low |
RNA Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$188.81M(-10.3%) | -$612.46M(-17.4%) |
| Jun 2025 | - | -$171.14M(-30.1%) | -$521.78M(-20.4%) |
| Mar 2025 | - | -$131.52M(-8.7%) | -$433.27M(-14.3%) |
| Dec 2024 | -$378.94M(-60.8%) | -$120.99M(-23.3%) | -$378.94M(-16.7%) |
| Sep 2024 | - | -$98.13M(-18.8%) | -$324.69M(-13.9%) |
| Jun 2024 | - | -$82.63M(-7.0%) | -$285.18M(-11.8%) |
| Mar 2024 | - | -$77.19M(-15.6%) | -$255.19M(-8.3%) |
| Dec 2023 | -$235.60M(-31.7%) | -$66.74M(-13.8%) | -$235.60M(-6.1%) |
| Sep 2023 | - | -$58.63M(-11.4%) | -$222.08M(-6.6%) |
| Jun 2023 | - | -$52.63M(+8.6%) | -$208.38M(-3.1%) |
| Mar 2023 | - | -$57.60M(-8.2%) | -$202.05M(-12.9%) |
| Dec 2022 | -$178.91M | -$53.23M(-18.5%) | -$178.91M(-8.9%) |
| Sep 2022 | - | -$44.93M(+3.0%) | -$164.24M(-10.5%) |
| Jun 2022 | - | -$46.30M(-34.4%) | -$148.59M(-15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$34.46M(+10.6%) | -$128.65M(-9.0%) |
| Dec 2021 | -$118.05M(-166.6%) | -$38.55M(-31.6%) | -$118.05M(-23.2%) |
| Sep 2021 | - | -$29.28M(-11.0%) | -$95.80M(-22.8%) |
| Jun 2021 | - | -$26.37M(-10.5%) | -$77.98M(-25.8%) |
| Mar 2021 | - | -$23.86M(-46.4%) | -$61.98M(-40.0%) |
| Dec 2020 | -$44.28M(-155.5%) | -$16.29M(-42.1%) | -$44.28M(-58.2%) |
| Sep 2020 | - | -$11.47M(-10.6%) | -$27.98M(-28.8%) |
| Jun 2020 | - | -$10.37M(-68.6%) | -$21.72M(-42.3%) |
| Mar 2020 | - | -$6.15M(-18.1%) | -$15.26M(-35.2%) |
| Dec 2019 | -$17.33M(-65.1%) | - | - |
| Sep 2019 | - | -$5.21M(-33.3%) | -$11.29M(-85.6%) |
| Jun 2019 | - | -$3.90M(-79.6%) | -$6.08M(-179.6%) |
| Mar 2019 | - | -$2.17M | -$2.17M |
| Dec 2018 | -$10.50M | - | - |
FAQ
- What is Avidity Biosciences, Inc. annual operating income?
- What is the all-time high annual operating profit for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. annual operating profit year-on-year change?
- What is Avidity Biosciences, Inc. quarterly operating income?
- What is the all-time high quarterly operating profit for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. quarterly operating profit year-on-year change?
- What is Avidity Biosciences, Inc. TTM operating income?
- What is the all-time high TTM operating profit for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. TTM operating profit year-on-year change?
What is Avidity Biosciences, Inc. annual operating income?
The current annual operating profit of RNA is -$378.94M
What is the all-time high annual operating profit for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high annual operating income is -$10.50M
What is Avidity Biosciences, Inc. annual operating profit year-on-year change?
Over the past year, RNA annual operating income has changed by -$143.34M (-60.84%)
What is Avidity Biosciences, Inc. quarterly operating income?
The current quarterly operating profit of RNA is -$188.81M
What is the all-time high quarterly operating profit for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high quarterly operating income is -$2.17M
What is Avidity Biosciences, Inc. quarterly operating profit year-on-year change?
Over the past year, RNA quarterly operating income has changed by -$90.67M (-92.40%)
What is Avidity Biosciences, Inc. TTM operating income?
The current TTM operating profit of RNA is -$612.46M
What is the all-time high TTM operating profit for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high TTM operating income is -$2.17M
What is Avidity Biosciences, Inc. TTM operating profit year-on-year change?
Over the past year, RNA TTM operating income has changed by -$287.76M (-88.63%)